Tele: 561.316.3330

Breaking Medical Device Industry News

Friday, October 22, 2021



Dan McCoy, MD, Named Chief Medical Officer at Catapult Health

Catapult’s forward-looking innovation and leadership in virtual clinical care were key drivers in bringing McCoy and Michel together

Dan McCoy MD will provide clinical and strategic leadership to the company as he joins Catapult’s executive team.

Dr. McCoy is a physician, entrepreneur, and communicator who is passionate about improving the way healthcare is delivered. In his time as president of Blue Cross and Blue Shield of Texas, he was instrumental in the creation of the C1 Innovation Lab in Dallas, with the goal of uniting clinicians, members, advocates, and innovators to work together to generate solutions. Dr. McCoy’s previous roles at BCBSTX included divisional senior vice president of the Texas market strategy, and Texas plan chief medical officer. During his term as president (2016-2020), BCBSTX experienced the largest growth in membership, underwriting margin and revenue in the company’s 90-year history.

“I’m excited about the opportunity to contribute to the already great work of Catapult Health,” said Dr. McCoy. “I’ve watched them from their early days and have always been impressed with how well they’ve focused on the patient, while being nimble and responsive to major changes in the healthcare environment.”

“I’ve known and worked with Dr. McCoy for the better part of a decade, and now is the perfect time for him to join our team,” said Michel. “Over the past year, we created and launched the nation’s first VirtualCheckup®, leveraging our world-class clinical expertise, sophisticated technology, and ability to scale up quickly. Dr. McCoy’s skills and experiences are very well matched with our go-forward strategy.”

Other Articles

Zerigo Health Raises $43 Million in Series B Funding

This round will allow Zerigo Health to respond to the increasing demand for its innovative connected chronic skin condition solution for the over 40 million Americans living with psoriasis, vitiligo, and eczema.

DentalMonitoring, the Leading AI-Based Dental Software Company, Announces a $150 Million Growth Financing, Reaching a Valuation Over $1 Billion

The round is led by a new investment of $90 million from Mérieux Equity Partners and $60 million from Vitruvian Partners, an existing financial investor, demonstrating confidence in the company’s ambitious plans.

Contraline Closes $10.7 Million Series A Financing to Become a Clinical Stage Company

This infusion of capital will support the initiation of a first-in-human trial of ADAM™, the world’s first hydrogel implant designed to provide long-lasting, non-permanent contraception for men.

Endolumik Inc. of Morgantown Secures $175,000 Angel Investment from Country Roads Angel Network

Endolumik, Inc. was founded in May 2020 by Mara McFadden, chief executive officer, and Dr. Nova Szoka, inventor of the surgical device.

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

Global Healthcare Exchange Announces Acquisition of Explorer Surgical

Explorer Surgical will operate as a wholly-owned subsidiary of GHX.

By using this website you agree to accept Medical Device News Magazine Privacy Policy